Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma

por Modak, Shakeel, Kushner, Brian H., Kramer, Kim, Vickers, Andrew, Cheung, Irene Y., Cheung, Nai-Kong V.
Publicado 2013

Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Man...

por Mora, Jaume, Chan, Godfrey C., Morgenstern, Daniel A., Nysom, Karsten, Bear, Melissa K., Tornøe, Karen, Kushner, Brian H.
Publicado 2022

Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma

por Cardenas, Fiorella Iglesias, Mauguen, Audrey, Cheung, Irene Y., Kramer, Kim, Kushner, Brian H., Ragupathi, Govind, Cheung, Nai-Kong V., Modak, Shakeel
Publicado 2021

Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Desmoplastic Small Round Cell Tumor

por Forlenza, Christopher J., Kushner, Brian H., Kernan, Nancy, Boulad, Farid, Magnan, Heather, Wexler, Leonard, Wolden, Suzanne L., LaQuaglia, Michael P., Modak, Shakeel
Publicado 2015

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-G(D2) immunotherapy and isotretinoin

por Kushner, Brian H., Ostrovnaya, Irina, Cheung, Irene Y., Kuk, Deborah, Modak, Shakeel, Kramer, Kim, Roberts, Stephen S., Basu, Ellen M., Yataghene, Karima, Cheung, Nai-Kong V.
Publicado 2015

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease

por Fong, Christina, Kushner, Brian H., Di Giannatale, Angela, Gundem, Gunes, Li, Shanita, Roberts, Stephen S., Basu, Ellen M., Price, Anita, Cheung, Nai-Kong V., Modak, Shakeel
Publicado 2023

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

por Lavarino, Cinzia, Cheung, Nai-Kong V, Garcia, Idoia, Domenech, Gema, de Torres, Carmen, Alaminos, Miguel, Rios, Jose, Gerald, William L, Kushner, Brian, LaQuaglia, Mike, Mora, Jaume
Publicado 2009

Germline BRCA2 mutations detected in pediatric sequencing studies impact parents’ evaluation and care

por Walsh, Michael F., Kennedy, Jennifer, Harlan, Megan, Kentsis, Alex, Shukla, Neerav, Musinsky, Jacob, Roberts, Stephen, Kung, Andrew L., Robson, Mark, Kushner, Brian H., Meyers, Paul, Offit, Kenneth
Publicado 2017

MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G(D2) immunotherapy

por Kushner, Brian H., LaQuaglia, Michael P., Modak, Shakeel, Wolden, Suzanne L., Basu, Ellen M., Roberts, Stephen S., Kramer, Kim, Yataghene, Karima, Cheung, Irene Y., Cheung, Nai-Kong V
Publicado 2017

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors

por Becher, Oren J., Millard, Nathan E., Modak, Shakeel, Kushner, Brian H., Haque, Sofia, Spasojevic, Ivan, Trippett, Tanya M., Gilheeney, Stephen W., Khakoo, Yasmin, Lyden, David C., De Braganca, Kevin C., Kolesar, Jill M., Huse, Jason T., Kramer, Kim, Cheung, Nai-Kong V., Dunkel, Ira J.
Publicado 2017

Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

por Kramer, Kim, Pandit-Taskar, Neeta, Kushner, Brian H., Zanzonico, Pat, Humm, John L., Tomlinson, Ursula, Donzelli, Maria, Wolden, Suzanne L., Haque, Sophia, Dunkel, Ira, Souweidane, Mark M., Greenfield, Jeffrey P., Tickoo, Satish, Lewis, Jason S., Lyashchenko, Serge K., Carrasquillo, Jorge A., Chu, Bae, Horan, Christopher, Larson, Steven M., Cheung, Nai-Kong V., Modak, Shakeel
Publicado 2022